In this Section
3056.0 Drug & Pharmacy: Marketing & Monitoring
Monday, October 31, 2011: 8:30 AM
Additional research is needed to evaluate policy tradeoffs that inform public health decision-making, and ensure that scarce public dollars achieve the greatest value for money spent. The US Food and Drug Administration (FDA) conducts enforcement activities to protect the public health by assuring the safety, effectiveness, and security of pharmaceuticals. These enforcement activities include warning letters and notice of violation letters to pharmaceutical companies.
Session Objectives: 1. To explore a set of domestic drug policies, including FDA enforcement for safety and effectiveness; and cost containment efforts' effect on Medicaid expenditures; 2. To examine pharmaceutical companies' research and development approaches for cost savings; 3. To report on ethical dimensions of outsourcing clinical trials in light of international initiatives; 4. To discuss how the integration of such research findings may have implications for public health pharmacy practice
Jack Warren Salmon, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Medical Care
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)
See more of: Medical Care